Work

Erenumab Immunogenicity: a Pooled Analysis of Phase 2 and Phase 3 Migraine Prevention Clinical Trials (P4.098)

Year: 2018

Type: article

Source: Neurology

DOI: 10.1212/wnl.90.15_supplement.p4.098

Authors: Bert Vargas, Amaal Starling, Stephen Silberstein, Yanchen Zhou, Marie-Louise Trotman, Fei Xue, Farhad Sahebkar-Moghaddam, Hernan Picard, Daniel Mikol

Institutions: The University of Texas Southwestern Medical Center, Mayo Clinic in Arizona, Thomas Jefferson University, Amgen (United States)

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2803772575

FWCI: 1.179

Cites:

Cited by: 6

Related to: 10